Shares of Forian Inc. (NASDAQ:FORA - Get Free Report) fell 3.1% during trading on Wednesday . The company traded as low as $1.87 and last traded at $1.87. 1,182 shares were traded during trading, a decline of 93% from the average session volume of 16,762 shares. The stock had previously closed at $1.93.
Forian Price Performance
The company has a market capitalization of $63.48 million, a price-to-earnings ratio of -22.61 and a beta of 1.04. The business has a fifty day moving average price of $2.03 and a 200 day moving average price of $2.12.
Insider Transactions at Forian
In other news, CEO Max C. Wygod acquired 12,320 shares of the stock in a transaction dated Tuesday, February 11th. The shares were acquired at an average cost of $2.67 per share, for a total transaction of $32,894.40. Following the completion of the transaction, the chief executive officer now owns 1,324,500 shares in the company, valued at approximately $3,536,415. This trade represents a 0.94 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 31.30% of the company's stock.
Institutional Trading of Forian
A number of institutional investors and hedge funds have recently modified their holdings of FORA. Elser Financial Planning Inc bought a new stake in shares of Forian during the fourth quarter valued at approximately $1,151,000. Virtu Financial LLC bought a new stake in shares of Forian during the fourth quarter valued at approximately $30,000. Renaissance Technologies LLC increased its position in shares of Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company's stock valued at $73,000 after purchasing an additional 11,601 shares during the period. Finally, Oracle Investment Management Inc. increased its position in shares of Forian by 0.7% during the fourth quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company's stock valued at $2,814,000 after purchasing an additional 10,000 shares during the period. 19.25% of the stock is currently owned by institutional investors.
Forian Company Profile
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Further Reading
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
